FDA Grants Fast Track Status To MyVax(R) Personalized Immunotherapy For Follicular Non-Hodgkin's Lymphoma (Medical News Today)
GenitopeCorporation (Nasdaq: GTOP) today announced that MyVax(R) personalizedimmunotherapy received Fast Track designation from the U.S. Food & DrugAdministration (FDA) for the treatment of follicular non-Hodgkin's Lymphoma(fNHL). [click link for full article]

Baxter Receives Tentative FDA Approvals For Ondansetron Injection In Vials And Premix Containers (RedNova)
DEERFIELD, Ill., June 15 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced that it has received tentative approvals from the U.S.

Baxter Gets Tentative OK for Nausea Drug (AP via Yahoo! Finance)
Medical products maker Baxter International Inc. said Thursday its subsidiary received tentative approvals from the Food and Drug Administration for its ondansetron injection for the prevention of nausea and vomiting.